NasdaqCM - Delayed Quote USD

enVVeno Medical Corporation (NVNO)

Compare
3.3700 -0.2400 (-6.65%)
At close: 4:00 PM EST
Advanced Chart
Loading Chart for NVNO
DELL
  • Previous Close 3.6100
  • Open 3.6100
  • Bid 3.3400 x 200
  • Ask 3.4000 x 100
  • Day's Range 3.3200 - 3.6670
  • 52 Week Range 3.0120 - 6.9700
  • Volume 316,234
  • Avg. Volume 128,825
  • Market Cap (intraday) 59.096M
  • Beta (5Y Monthly) 1.22
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2900
  • Earnings Date Oct 31, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 18.00

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

www.envveno.com

31

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about enVVeno Medical Corporation

Recent News: NVNO

View More
View More

Performance Overview: NVNO

Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NVNO
34.44%
S&P 500
24.05%

1-Year Return

NVNO
19.57%
S&P 500
31.08%

3-Year Return

NVNO
54.46%
S&P 500
25.95%

5-Year Return

NVNO
76.76%
S&P 500
89.64%

Compare To: NVNO

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

NVNO
enVVeno Medical Corporation
3.3700
-6.65%
Mkt Cap 59.096M
Industry Medical Devices
IRIX
IRIDEX Corporation
1.7400
-2.25%
Mkt Cap 28.947M
Industry Medical Devices
MYO
Myomo, Inc.
4.9200
-0.20%
Mkt Cap 148.81M
Industry Medical Devices
DCTH
Delcath Systems, Inc.
9.63
-2.83%
Mkt Cap 307.908M
Industry Medical Devices
LNSR
LENSAR, Inc.
7.28
-2.54%
Mkt Cap 84.556M
Industry Medical Devices
HSCS
HeartSciences Inc.
2.6400
-3.30%
Mkt Cap 2.412M
Industry Medical Devices
NVRO
Nevro Corp.
4.2300
-0.24%
Mkt Cap 158.505M
Industry Medical Devices
ECOR
electroCore, Inc.
9.94
-1.49%
Mkt Cap 65.153M
Industry Medical Devices
RSLS
ReShape Lifesciences Inc.
5.04
-1.37%
Mkt Cap 3.592M
Industry Medical Devices
MOVE
Movano Inc.
3.0100
-1.95%
Mkt Cap 19.967M
Industry Medical Devices
NARI
Inari Medical, Inc.
49.00
-3.87%
Mkt Cap 2.869B
Industry Medical Devices

Statistics: NVNO

View More

Valuation Measures

Annual
As of 11/19/2024

  • Market Cap

    63.30M

  • Enterprise Value

    16.07M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.34

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -37.28%

  • Return on Equity (ttm)

    -58.77%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -21.24M

  • Diluted EPS (ttm)

    -1.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    48.38M

  • Total Debt/Equity (mrq)

    2.42%

  • Levered Free Cash Flow (ttm)

    -9.84M

View More

Research Analysis: NVNO

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

18.00
18.00 Average
3.3700 Current
18.00 High
 
View More

Company Insights: NVNO

People Also Watch

RVPH Reviva Pharmaceuticals Holdings, Inc.
1.2150
-3.57%
 
UNCY Unicycive Therapeutics, Inc.
0.5094
+5.03%
 
EYEN Eyenovia, Inc.
0.0924
-22.48%
 
TPST Tempest Therapeutics, Inc.
0.8984
+3.85%
 
ACXP Acurx Pharmaceuticals, Inc.
1.3900
-16.77%
 
RNAZ TransCode Therapeutics, Inc.
0.3362
+2.50%
 
CGTX Cognition Therapeutics, Inc.
0.4400
-0.90%
 
AVTX Avalo Therapeutics, Inc.
10.90
-1.36%
 
CNTB Connect Biopharma Holdings Limited
1.0500
+9.37%
 
SABS SAB Biotherapeutics, Inc.
3.0600
-5.56%
 
LTRN Lantern Pharma Inc.
2.9400
-4.55%
 
XLO Xilio Therapeutics, Inc.
0.9412
-7.73%
 
NRSN NeuroSense Therapeutics Ltd.
0.9901
-11.20%
 
CYTH Cyclo Therapeutics, Inc.
0.7088
+4.08%
 
BBLG Bone Biologics Corporation
1.2600
-4.55%
 
NRXP NRx Pharmaceuticals, Inc.
1.2100
-1.22%